A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy

NCT07654972 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight

Interventions

DRUG: LY4174794
DRUG: LY4174794
DRUG: Placebo

Sponsor

Eli Lilly and Company